Could a heart drug rewire the brain to ease chronic pain?
NCT ID NCT05085782
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new approach for chronic low-back pain and fibromyalgia in 48 adults. Participants received pain education plus propranolol (a blood pressure drug) to help the brain 'relearn' and reduce pain. The goal was to see if the treatment is feasible and acceptable, and to measure its effect on pain and function one month later.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CRCHUS: Centre de recherche du centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, J1H5N4, Canada
-
Centre de recherche sur le vieillissement (CdRV)
Sherbrooke, Quebec, J1H 4C4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could hidden sleep problems be worsening fibromyalgia?
- Which therapy eases back pain disability best? a Head-to-Head trial
- Electric boost for back pain? trial tests stimulation plus exercise
- Can a painless laser on the ear silence chronic pain in seniors?
- Can a nerve zap in the neck tame fibromyalgia pain?
- A stronger core, a lighter back? exercise trial targets chronic pain in older adults